ArticleBMC genomics2025
Genetic parameters estimation and optimization of genomic selection in mud crab (Scylla paramamosain): a case study for growth-related traits.
Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identification of SSR Markers Correlated with Growth Traits in Swimming Crab (International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundGenomic selection (GS) has become a preferred method for genetic improvement in aquaculture species. However, its application in mud crab (Scylla paramamosain) remains limited. Given that the prediction accuracy of GS varies across species and is influenced by several factors, including statistical models, marker density, and the size of the reference population, a systematic investigation of GS in mud crab is necessary. To explore the impact of these factors on GS and optimize the application strategies of GS in mud crab breeding, a total of 508 mud crabs were genotyped by the 40 K liquid SNP array (named "Xiexin No. 1") to estimate genetic parameters of growth traits and systematically investigate the impact of prediction models, SNP density, and reference population size on GS.
resultsResults showed that the genomic heritability for body weight (BW), carapace length (CL), carapace width (CW), and body height (BH) was 0.860 ± 0.043, 0.554 ± 0.081, 0.521 ± 0.083, and 0.597 ± 0.077, respectively. Different models (GBLUP, rrBLUP, BayesA, BayesB, BayesC, and BayesR) exhibited similar prediction accuracies for four growth-related traits, with ranges of 0.510-0.515, 0.569-0.574, 0.567-0.570, and 0.543-0.548 for BW, CL, CW, and BH, respectively, but GBLUP showed advantages in computational efficiency. Notably, the accuracy of GS for four growth-related traits would be further improved as the SNP density increased but began to plateau after 10 K SNPs. When SNP density increased from 0.5 K to 33 K, the average prediction accuracies of six models for BW, CL, CW, and BH were improved by 6.22%, 4.20%, 4.40%, and 5.23%, respectively. Moreover, the prediction accuracy of GS was also improved as the number of reference individuals increased. When the reference population size expanded from 30 to 400, the average prediction accuracies of six models for BW, CL, CW, and BH increased by 8.66%, 3.99%, 4.97% and 4.56%, respectively. In addtion, the prediction unbiasedness of GBLUP, BayesA, BayesB, and BayesC were close to 1, only when the reference population size was more than 150.
conclusionsTaken together, the reference population comprising at least 150 samples genotyped with over 10 K SNPs is the minimum standard for implementing GS of growth-related traits in mud crab. Our results would provide valuable insights and practical recommendations on implementing GS in mud crab genetic breeding programs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.